SOD1 and amyotrophic lateral sclerosis: By contrast, the spinal infusion of human NSCs into various spinal sections of the superoxide dismutase 1 (SOD1) rodent model of ALS slowed disease progression, delayed disease onset, and increased survival rates [65].